| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-05 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0001 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |